Argenx To Raise $300 million in U.S. public offering

Argenx To Raise $300 million in U.S. public offering

Submitted by admin on September 19, 2018 - 11:44am
Source: 
CP Wire
News Tags: 
Argenx
Headline: 
Argenx To Raise $300 million in U.S. public offering
snippet: 
  • argynx has 8 drugs in development
  • Partners include Abbvie, LEO Pharma, and Staten Biotech

Do Not Allow Advertisers to Use My Personal information